Montelukast Tillomed (Montelukast Sodium)

Montelukast Sodium works by selectively blocking the cysteinyl leukotriene receptor CysLT1. This inhibition prevents leukotrienes from causing bronchoconstriction, mucus production, and inflammation in the airways, thereby easing respiratory symptoms.

The appropriate dose of Montelukast Tillomed is determined by a qualified prescriber based on the patient’s age, condition severity, and clinical response. Dosage instructions are provided on the prescription label and should be followed exactly.

Safety data for Montelukast during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare professional before using this medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting bronchodilators. It is especially useful for patients with allergic components or exercise‑related symptoms, but it does not replace rescue inhalers for acute attacks.

Montelukast Tillomed should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, and store it out of direct sunlight to maintain stability.

Montelukast Tillomed is taken orally, usually as a tablet or chewable form, with or without food. The exact administration instructions, including timing relative to meals, are provided by the prescribing clinician.

Serious risks include rare allergic reactions such as rash, angioedema, or anaphylaxis, as well as neuropsychiatric events like mood changes, depression, or suicidal thoughts. Patients should seek immediate medical attention if they experience any of these symptoms.

Montelukast is contraindicated in individuals with known hypersensitivity to montelukast or any of its excipients. Patients with a history of severe allergic reactions to leukotriene modifiers should avoid this medication and discuss alternatives with their doctor.